UBS Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.3M | Buy |
1,021,556
+60,381
| +6% | +$2.14M | 0.01% | 1435 |
|
|
2025
Q1 | $32.6M | Sell |
961,175
-18,863
| -2% | -$640K | 0.01% | 1473 |
|
|
2024
Q4 | $31.9M | Buy |
980,038
+861,920
| +730% | +$28M | 0.01% | 1414 |
|
|
2024
Q3 | $5.76M | Sell |
118,118
-1,521
| -1% | -$74.1K | ﹤0.01% | 2154 |
|
|
2024
Q2 | $5.3M | Sell |
119,639
-8,477
| -7% | -$375K | ﹤0.01% | 2094 |
|
|
2024
Q1 | $7.19M | Sell |
128,116
-171,127
| -57% | -$9.6M | ﹤0.01% | 1860 |
|
|
2023
Q4 | $18M | Sell |
299,243
-2,332
| -0.8% | -$140K | 0.01% | 1141 |
|
|
2023
Q3 | $20.3M | Buy |
301,575
+160,446
| +114% | +$10.8M | 0.01% | 1032 |
|
|
2023
Q2 | $9.74M | Sell |
141,129
-2,437
| -2% | -$168K | ﹤0.01% | 1431 |
|
|
2023
Q1 | $6.92M | Buy |
143,566
+33,509
| +30% | +$1.62M | ﹤0.01% | 1615 |
|
|
2022
Q4 | $5.49M | Buy |
110,057
+11,766
| +12% | +$587K | ﹤0.01% | 1764 |
|
|
2022
Q3 | $4.01M | Buy |
98,291
+9,761
| +11% | +$398K | ﹤0.01% | 1868 |
|
|
2022
Q2 | $4.87M | Sell |
88,530
-13,065
| -13% | -$719K | ﹤0.01% | 1790 |
|
|
2022
Q1 | $3.69M | Sell |
101,595
-809
| -0.8% | -$29.4K | ﹤0.01% | 2173 |
|
|
2021
Q4 | $4.77M | Buy |
102,404
+45,748
| +81% | +$2.13M | ﹤0.01% | 2138 |
|
|
2021
Q3 | $2.86M | Buy |
56,656
+54,366
| +2,374% | +$2.75M | ﹤0.01% | 2478 |
|
|
2021
Q2 | $94K | Buy |
2,290
+433
| +23% | +$17.8K | ﹤0.01% | 4889 |
|
|
2021
Q1 | $54K | Sell |
1,857
-113
| -6% | -$3.29K | ﹤0.01% | 5466 |
|
|
2020
Q4 | $55K | Buy |
1,970
+802
| +69% | +$22.4K | ﹤0.01% | 5105 |
|
|
2020
Q3 | $36K | Buy |
1,168
+668
| +134% | +$20.6K | ﹤0.01% | 5008 |
|
|
2020
Q2 | $21K | Buy |
+500
| New | +$21K | ﹤0.01% | 5678 |
|